TITLE

Possible New Treatment for Severe 2009 H1N1 Infection

PUB. DATE
July 2011
SOURCE
International Journal of Virology;2011, Vol. 7 Issue 2, p79
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
65418217

 

Related Articles

  • The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand. HIGGINS, A. M.; PETTILÄ, V.; HARRIS, A. H.; BAILEY, M.; LIPMAN, J.; SEPPELT, I. M.; WEBB, S. A. // Anaesthesia & Intensive Care;May2011, Vol. 39 Issue 3, p384 

    The article discusses the results of a study which determines the critical care management of patients with influenza A/H1N1 and associated costs in intensive care units (ICU) and length of stay in hospital during southern hemisphere winter in Australia and New Zealand. According to the authors,...

  • C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. Zimmerman, Ofer; Rogowski, Ori; Aviram, Galit; Mizrahi, Michal; Zeltser, David; Justo, Dan; Dahan, Esther; Arad, Roy; Touvia, Oholi; Tau, Luba; Tarabeia, Jalal; Berliner, Shlomo; Paran, Yael // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p288 

    Background: Data for predicting which patients with pandemic influenza A (H1N1) infection are likely to run a complicated course are sparse. We retrospectively studied whether the admission serum C-reactive protein (CRP) levels can serve as a predictor of illness severity. Methods: Included were...

  • Structure of Intensive Care Unit and Clinical Outcomes in Critically Ill Patients with Influenza A/H1N1 2009. Jaehwa Cho; Hun Jae Lee; Sang-Bum Hong; Gee Young Suh; Moo Suk Park; Seok Chan Kim; Sang Hyun Kwak; Myung Goo Lee; Jae Min Lim; Huyn-Kyung Lee; Younsuck Koh // Korean Journal of Critical Care Medicine;2012, Vol. 27 Issue 2, p65 

    Background: During 2009 pandemic period, many Koreans were infected and admitted with Influenza A/H1N1. The primary aim of this study was to evaluate whether the structures of an intensive care unit (ICU) were associated with the outcomes of critically ill patients. Methods: This retrospective...

  • Concomitant Infections of Influenza A H1N1 and Disseminated Cryptococcosis in an HIV Seropositive Patient. Gupta, Ankit; Capoor, Malini R.; Gupta, Sonal; Sachdeva, Harish Chand // Journal of Laboratory Physicians;Jul-Dec2015, Vol. 7 Issue 2, p134 

    Respiratory viral infections, especially influenza have a potential to form a fatal association with cryptococcosis in the setting of compromised immunity. Considering the lethality of these two infections, we report an unusual case of dual infection of pandemic influenza A H1N1 and disseminated...

  • Possible Neuropsychiatric Reaction to High-Dose Oseltamivir during Acute 2009 H1N1 Influenza A Infection. Nakamura, Kenta; Schwartz, Brian S.; Lindegårdh, Niklas; Keh, Chris; Guglielmo, B. Joseph // Clinical Infectious Diseases;4/1/2010, Vol. 50 Issue 7, pe47 

    The safety of high-dose oseltamivir during treatment of 2009 H1N1 influenza A infection for critically ill patients is unknown. Here we report on a case patient with severe, delayed-onset neuropsychiatric symptoms after administration of high-dose oseltamivir. Clinicians should be vigilant to...

  • CDC reports multiple cases of oseltamivir-resistant influenza A H1N1.  // Infectious Diseases in Children;Oct2009, Vol. 22 Issue 10, p34 

    The article focuses on the cases of oseltamivir-resistant influenza A H1N1 reported by the U.S. Centers for Disease Control and Prevention (CDC).

  • Oseltamivir/peramivir.  // Reactions Weekly;7/10/2010, Issue 1309, p31 

    The article describes the case of two immunocompromised patients who acquired influenza A H1N1 infections resistant to oseltamivir and peramivir.

  • Oseltamivir.  // Reactions Weekly;11/13/2010, Issue 1327, p28 

    The article describes two cases of intratreatment resistance to oseltamivir in pandemic influenza A H1N1 virus infection of a two-year-old boy and a one-year-old girl.

  • Biochemistry: New study shows why swine flu virus develops drug resistance.  // Biomedical Market Newsletter;6/1/2012, Vol. 21, p1 

    The article offers information on a study which shows mechanism used by swine flu virus to resist action of anti flu drugs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics